Company Filing History:
Years Active: 1998-2000
Title: Mark S Hanson: Innovator in Genetic Research
Introduction
Mark S Hanson is a notable inventor based in Columbia, MD (US). He has made significant contributions to the field of genetic research, particularly in the development of vaccines and antibiotic resistance solutions. With a total of 2 patents, his work has implications for public health and medical advancements.
Latest Patents
Hanson's latest patents include the H. influenzae HxuB and HxuC genes, proteins, and methods of use. These patents disclose the hxuB and hxuC genes and DNA segments from H. influenzae, including H. influenzae type b (Hib) and nontypeable H. influenzae (NTHI). The HxuB and HxuC proteins are surface-expressed and are being considered for use in vaccines against H. influenzae infections, particularly for children and individuals who do not respond well to capsular-based vaccines. Additionally, he has developed vectors and prokaryotes that can autocatalytically delete antibiotic resistance markers, which can be utilized in vaccine development to mitigate the risks associated with antibiotic resistance.
Career Highlights
Throughout his career, Mark S Hanson has worked with prominent organizations such as MedImmune Limited and the University of Texas System. His experience in these institutions has allowed him to collaborate on groundbreaking research and innovations in the field of genetics and immunology.
Collaborations
Hanson has collaborated with notable colleagues, including Shirley L Haun and Charles K Stover. These partnerships have contributed to the advancement of his research and the successful development of his patents.
Conclusion
Mark S Hanson is a distinguished inventor whose work in genetic research has the potential to impact vaccine development and antibiotic resistance solutions. His contributions are vital to advancing public health initiatives and improving medical treatments.